» Articles » PMID: 38896867

Development and Validation of a Clinical Decision Tool for Preoperative Micropapillary and Solid Pattern Lung Adenocarcinoma of CT ≤2 cm

Overview
Journal Int J Surg
Specialty General Surgery
Date 2024 Jun 19
PMID 38896867
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Micropapillary (MP) and solid (S) pattern adenocarcinoma are highly malignant subtypes of lung adenocarcinoma. In today's era of increasingly conservative surgery for small lung cancer, effective preoperative identification of these subtypes is greatly important for surgical planning and the long-term survival of patients.

Methods: For this retrospective study, the presence of MP and/or S was evaluated in 2167 consecutive patients who underwent surgical resection for clinical stage IA1-2 lung adenocarcinoma. MP and/or S pattern-positive patients and negative-pattern patients were matched at a ratio of 1:3. The Lasso regression model was used for data dimension reduction and imaging signature building. Multivariate logistic regression was used to establish the predictive model, presented as an imaging nomogram. The performance of the nomogram was assessed based on calibration, identification, and clinical usefulness, and internal and external validation of the model was conducted.

Results: The proportion of solid components (PSC), Sphericity, entropy, Shape, bronchial honeycomb, nodule shape, sex, and smoking were independent factors in the prediction model of MP and/or S lung adenocarcinoma. The model showed good discrimination with an area under the receiver operating characteristic curve of 0.85. DCA demonstrated that the model could achieve good benefits for patients. Restricted cubic spline analysis suggested a significant increase in the proportion of MP and/or S from 11 to 48% when the PSC value was 68%.

Conclusion: Small MP and/or S adenocarcinoma can be effectively identified preoperatively by their typical three-dimensional and 2D imaging features.

Citing Articles

Clinical, pathological, and computed tomography morphological features of lung cancer with spread through air spaces.

Zhang X, Qiao W, Shen J, Jiang Q, Pan C, Wang Y Transl Lung Cancer Res. 2024; 13(10):2802-2812.

PMID: 39507029 PMC: 11535835. DOI: 10.21037/tlcr-24-715.

References
1.
Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

2.
Li J, Xia T, Yang X, Dong X, Liang J, Zhong N . Malignant solitary pulmonary nodules: assessment of mass growth rate and doubling time at follow-up CT. J Thorac Dis. 2018; 10(Suppl 7):S797-S806. PMC: 5945695. DOI: 10.21037/jtd.2018.04.25. View

3.
Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y . Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998; 351(9111):1242-5. DOI: 10.1016/S0140-6736(97)08229-9. View

4.
Nitadori J, Bograd A, Kadota K, Sima C, Rizk N, Morales E . Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. J Natl Cancer Inst. 2013; 105(16):1212-20. PMC: 3748005. DOI: 10.1093/jnci/djt166. View

5.
Su H, Xie H, Dai C, Zhao S, Xie D, She Y . Procedure-specific prognostic impact of micropapillary subtype may guide resection strategy in small-sized lung adenocarcinomas: a multicenter study. Ther Adv Med Oncol. 2020; 12:1758835920937893. PMC: 7336827. DOI: 10.1177/1758835920937893. View